Crinetics Pharmaceuticals Stock Is Showing Strong Insider Interest
Kailas Salunkhe-
April 21, 2021, 10:32 AM EDT
SHARE ON:
CRNX) has seen a key corporate insider snap up shares recently.
Regulations require corporate insiders to make their trading activity public, and their actions could signal to investors that now is the time to get in on the action.
In the last 12 days, corporate insider Perceptive Advisors LLC, which owns a more than 10% stake in the company, has bought $5 million worth of Crinetics shares. (See Crinetics stock analysis on TipRanks)
On March 31, H. C. Wainwright analyst Douglas Tsao reiterated a Buy rating on the stock with a $30 price target (81.3% upside potential).